RT Journal Article
SR Electronic
T1 COVID-19 Sniffer Dog experimental training: which protocol and which implications for reliable identification?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.02.21257981
DO 10.1101/2021.06.02.21257981
A1 Angeletti, Silvia
A1 Travaglino, Francesco
A1 Spoto, Silvia
A1 Pascarella, Maria Chiara
A1 Mansi, Giorgia
A1 De Cesaris, Marina
A1 Sartea, Silvia
A1 Giovanetti, Marta
A1 Fogolari, Marta
A1 Plescia, Davide
A1 Macera, Massimiliano
A1 Incalzi, Raffaele Antonelli
A1 Ciccozzi, Massimo
YR 2021
UL http://medrxiv.org/content/early/2021/06/03/2021.06.02.21257981.abstract
AB The introduction of trained sniffer dogs for COVID-19 disease detection could be an opportunity, as previously described for other diseases. Dogs could be trained to detect volatile organic compounds (VOCs), the whiff of COVDI-19 disease. Dogs involved in the study were three one male and two females from different breeds, Black German Shepherd, German Shepherd and Dutch Shepherd. The training was performed using sweat samples from COVID-19 positive apteints and from covid-19 free patients admitted at the University Hospital Campus Bio-medico of Rome. Gauze with sweat were collected in glass jar with metal top and put in metal boxes used for dog training. The dog training protocol was performed in two phase: the olfactory conditioning and the olfactory discrimintaion research. The training palnning was focused on the switch moment for the sniffer dog, the moment when the dog was able to identify VOCs specific for COVID-19 disease. At this time the dog was able to identify VOCs specific for COVID-19 disease with significant reliability, in terms of number of correct versus uncorrect (p<0.0001) reporting. In conclusion, this protocol could provide a useful tool for sniffer dogs training and their introduction in mass screening context, cheaper and faster than a conventional testing method.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNot applicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Local Ethic Committee of University campus Bio-Medico of Rome (PAR 17.21 OSS). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable